Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.

NCT06342544 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT06342544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Phase 3
Overall status
Recruiting
Start date
April 29, 2025
Completion date
June 30, 2029
Enrollment
128 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

ocular myasthenia gravis